Ki |
- |
EC50 |
|
IC50 |
4.7±0.22 μM(RatAChE), 12.1±0.27 μM(RatBChE), 6.80±0.31 μM(HuAChE), 16.1±0.52 μM(HuBChE) |
Inhibition |
77.9±0.72%(self-induced Aβ1-42 aggregation), 73.6±0.87%(HuAChE-induced Aβ1-42 aggregation), 78.9±0.64%(Cu2+-induced Aβ1-42 aggregation) |
Toxicity |
|
ROS(reactive oxygen species) |
|
Metal Chelating |
Cu2+ |
BBB(blood-brain barrier) |
PASS |
Target Protein |
Butyrylcholinesterase (BChE) |
Effects |
Show significant antioxidant activity and is a reversible and potent huAChE and huBChE inhibitor, remarkably inhibit self- and Cu2+-mediated Aβ1-42 aggregation, show good BBB penetration |
Research Models |
Molecular docking, in PC12 cell, in Kunming mice, in vitro |
Ref. Link |
|